494 Preliminary results from a phase I clinical trial of the bioreductive drug, RH1

Citation

• Ward, T. H., Danson, S., Dawson, M., Denneny, O., McGrath, H., Cummings, J., . . . Ranson, M. (2004). 494 Preliminary results from a phase I clinical trial of the bioreductive drug, RH1. European Journal of Cancer Supplements, 2(8), 151. doi:10.1016/s1359-6349(04)80502-0

Digital Object Identifier (doi)

• 10.1016/s1359-6349(04)80502-0

Web Of Science Accession Number

Start Page

• 151

Volume

• 2

Issue

• 8

Abstract

UOW Authors

•   Ranson, Marie (external author)

Publication Date

• 2004

Publisher

• Elsevier BV 

Published In

• European Journal of Cancer Supplements  Journal

Citation

• Ward, T. H., Danson, S., Dawson, M., Denneny, O., McGrath, H., Cummings, J., . . . Ranson, M. (2004). 494 Preliminary results from a phase I clinical trial of the bioreductive drug, RH1. European Journal of Cancer Supplements, 2(8), 151. doi:10.1016/s1359-6349(04)80502-0

Digital Object Identifier (doi)

• 10.1016/s1359-6349(04)80502-0

Web Of Science Accession Number

Start Page

• 151

Volume

• 2

Issue

• 8